| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/03/2002 | US6489144 Culturing cells that overproduce double-stranded-rna-dependent kinase and treatment with inducer |
| 12/03/2002 | US6489141 Codon replacement for higher translational efficiency |
| 12/03/2002 | US6489137 For use in cancer diagnostics; detection of the loss and or alteration of wild-type hubub1 genes in tumor tissues |
| 12/03/2002 | US6489135 Evaluating health, implantability, and likelihood of pregnancy developing to term; reducing frequency of multiple births |
| 12/03/2002 | US6489134 Kinesin motor modulators derived from the marine sponge Adocia |
| 12/03/2002 | US6489133 Reflectance reading; porous matrix impregnated with reagent;measuring glucose in blood |
| 12/03/2002 | US6489130 Death associated kinase containing ankyrin repeats (DAKAR) |
| 12/03/2002 | US6489122 Chlamydia pneumoniae antigenic polypeptides, which comprise polypeptide a containing a sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1, dnas encoding the antigenic polypeptides, or dnas complementary thereto; |
| 12/03/2002 | US6489116 Sensitive, multiplexed diagnostic assays for protein analysis |
| 12/03/2002 | US6489115 Genetic assays for trinucleotide repeat mutations in eukaryotic cells |
| 12/03/2002 | US6489114 Process for labeling a ribonucleic acid, and labeled RNA fragments which are obtained thereby |
| 12/03/2002 | US6489112 Preparing nanoscale reactions using nucleic acids are presented. nucleic acids are captured saturably, yet reversibly, on the internal surface of the reaction chamber, typically a capillary. excess nucleic acid is removed and the |
| 12/03/2002 | US6489111 Apparatus and methods for immobilized DNA library preparation and gene amplification |
| 12/03/2002 | US6489110 Amplifying a target containing mrna coding for the elongation factor ef-tu, determining the presence and/or amount of said mrna, and assessing mycobacterial viability based on the determination of the presence and/or amount of said mrna. |
| 12/03/2002 | US6489109 Transcription-based gene mapping |
| 12/03/2002 | US6489107 Method for identifying Escherichia coli strain DSM 6601 |
| 12/03/2002 | US6489106 Control of the expression of anchored genes using micron scale heaters |
| 12/03/2002 | US6489105 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype P53 |
| 12/03/2002 | US6489104 Screening for a dna encoding a protein that regulates the human p27.sup.kip1 promoter activity of a promoter dna, said promoter dna comprising at least a substantial portion of a fragment extending from nucleotide 2795 to nucleotide 3133 of |
| 12/03/2002 | US6489103 In vitro sorting method |
| 12/03/2002 | US6489102 Made using a reversible protecting group to reversibly modify omega-functionalized alkanethiols self-assembled on metal substrates, and immobilizing cells or biomolecules; use in surface plasmon resonance (spr) imaging |
| 12/03/2002 | US6489099 Detection of DNA damaging agents |
| 12/03/2002 | US6489098 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 12/03/2002 | US6489097 Method for the detection of telomerase activity |
| 12/03/2002 | US6489096 Systems and methods for enhanced quantitative analysis of hybridization intensity measurements obtained from oligonucleotide probes and other probes exposed to target samples are provided by virtue of the present invention. one |
| 12/03/2002 | US6489095 Detecting preferential physical and hereditary genetic disorders; obtain sample, extract mitochondrial nucleotide sequences, compare to control, detect adjustment in seqences, evaluate for physical or genetic disorder |
| 12/03/2002 | US6489094 Automatic |
| 12/03/2002 | US6488935 Dna coding for a peptide of a papilloma virus major capsid protein and a papilloma virus genome, respectively |
| 12/03/2002 | US6488828 Recloseable biosensor |
| 12/03/2002 | CA2254853C Compositions and methods for screening antimicrobials |
| 12/03/2002 | CA2042293C Reverse sample genome probing of sulphate-reducing bacteria |
| 11/30/2002 | CA2388268A1 Methods of determining polypeptide structure and function |
| 11/30/2002 | CA2387406A1 Protein kinase peptide substrate determination using peptide libraries |
| 11/30/2002 | CA2386755A1 Fluorescent group-containing carbodiimide compound and process for producing the compound |
| 11/30/2002 | CA2384352A1 Novel polynucleotides from streptomyces avermitilis |
| 11/29/2002 | WO2001092476A2 In vitro tissue test system |
| 11/29/2002 | CA2410946A1 In vitro tissue test system |
| 11/28/2002 | WO2002095416A2 Method for identifying micro-organisms using mass spectrometry |
| 11/28/2002 | WO2002095413A2 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia |
| 11/28/2002 | WO2002095410A1 Adherent entities and uses therefor |
| 11/28/2002 | WO2002095402A2 Individualization of therapy with hyperlipidemia agents |
| 11/28/2002 | WO2002095399A2 Method for certifying chondrocytes for use in cartilage regeneration |
| 11/28/2002 | WO2002095385A1 Biosensor |
| 11/28/2002 | WO2002095375A1 Semen analysis |
| 11/28/2002 | WO2002095363A2 Methods for attenuation of virulence in bacteria |
| 11/28/2002 | WO2002095075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 11/28/2002 | WO2002095074A1 Foot and mouth disease virus diagnostic and methods |
| 11/28/2002 | WO2002095071A2 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error |
| 11/28/2002 | WO2002095070A2 Polynucleotide sequencing method |
| 11/28/2002 | WO2002095069A2 Methods |
| 11/28/2002 | WO2002095068A2 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides |
| 11/28/2002 | WO2002095067A2 INTERFERON α-14 POLYMORPHISM |
| 11/28/2002 | WO2002095066A2 Detecting microorganisms of the yersinia pestis/yersinia pseudotuberculosis species |
| 11/28/2002 | WO2002095065A2 G-protein coupled receptor arrays |
| 11/28/2002 | WO2002095064A1 Transporter arrays and methods and kits for producing and using the arrays |
| 11/28/2002 | WO2002095063A1 Pyruvate-kinase as a novel target molecule |
| 11/28/2002 | WO2002095061A1 Methods of screening test substances for treating or preventing diseases involving an oxidative stress |
| 11/28/2002 | WO2002095059A2 Selection of target sites for antisense attack of rna |
| 11/28/2002 | WO2002095058A2 Emission ratiometric indicators of phosphorylation |
| 11/28/2002 | WO2002095057A2 Pairs of nucleic acid probes with interactive signaling moieties and nucleic acid probes with enhanced hybridization efficiency and specificity |
| 11/28/2002 | WO2002095055A2 Compositions and methods for use in isolation of nucleic acid molecules |
| 11/28/2002 | WO2002095052A2 Pna probes, probe sets, methods and kits pertaining to the detection of candida |
| 11/28/2002 | WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules |
| 11/28/2002 | WO2002095050A2 Trinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 11/28/2002 | WO2002095039A1 Protease deficient caulobacter host cells |
| 11/28/2002 | WO2002095036A2 A novel intein and uses thereof |
| 11/28/2002 | WO2002095034A2 A retinoic acid metabolizing cytochrome p450 |
| 11/28/2002 | WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria |
| 11/28/2002 | WO2002095025A1 Novel smg-1 |
| 11/28/2002 | WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 11/28/2002 | WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 11/28/2002 | WO2002095000A2 Molecular toxicology modeling |
| 11/28/2002 | WO2002094997A2 Transcriptional regulation of target genes |
| 11/28/2002 | WO2002094995A2 Methods and compositions using genetic package display |
| 11/28/2002 | WO2002094990A2 Receptors and membrane-associated proteins |
| 11/28/2002 | WO2002094985A2 Beta-secretase substrates and uses thereof |
| 11/28/2002 | WO2002094982A2 Increasing bioavailability of carotenoids |
| 11/28/2002 | WO2002094976A2 Identification of antimicrobial agents |
| 11/28/2002 | WO2002094949A2 Detection method for identifying hydrolases |
| 11/28/2002 | WO2002094878A1 Hevein-binding monoclonal antibodies |
| 11/28/2002 | WO2002094874A2 Internalisation of virus into cells |
| 11/28/2002 | WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology |
| 11/28/2002 | WO2002094864A2 Human cdnas and proteins and uses thereof |
| 11/28/2002 | WO2002094863A2 INTERFERON-α INDUCED GENE |
| 11/28/2002 | WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 11/28/2002 | WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 11/28/2002 | WO2002094850A2 Haplotypes of the gnrh2 gene |
| 11/28/2002 | WO2002094780A2 Kinases and phosphatases |
| 11/28/2002 | WO2002094778A2 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
| 11/28/2002 | WO2002094777A2 Methods of detecting protein arginine methyltransferase, and uses related thereto |
| 11/28/2002 | WO2002094314A1 Tsg101 as inhibitor of hiv production |
| 11/28/2002 | WO2002094248A2 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample |
| 11/28/2002 | WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 11/28/2002 | WO2002094195A2 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents |
| 11/28/2002 | WO2002094194A2 Compositions and methods for inhibiting metastasis |
| 11/28/2002 | WO2002094193A1 Methods for inhibiting angiogenesis |
| 11/28/2002 | WO2002094185A2 Conjugates and compositions for cellular delivery |
| 11/28/2002 | WO2002094084A2 Bmpr1a involvement in juvenile polyposis |
| 11/28/2002 | WO2002083712A8 Transporters and ion channels |
| 11/28/2002 | WO2002077245A9 Assay for drug-induced recoding |